Track the AtaiBeckley Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.7bn. The latest transaction was reported on 9 July 2026 (Levée d'options). Among the most active insiders: Craig Kevin James. Every trade is free.
20
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€1m
6 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate AtaiBeckley Inc. Hold (neutral), based on 8 analysts. Average price target: US$9.09.
28Σ signal
Buys n/a€1m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
39,594 shares@ US$3.899100.0% of flowCommon StockSEC:0001140361-26-000415:0
20 of 20 declarations
About AtaiBeckley Inc.
AtaiBeckley Inc. is a company listed on the XNAS market, focused on the research and development of psychedelic treatments for mental health disorders. It collaborates with academic institutions and companies to advance in this innovative field.